| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print April 21, 2003
Oncology, Mayo Clinic, Rochester, MN 55905
Corresponding Author: karnitz.larry{at}mayo.edu
Rad9, a key component of genotoxin-activated checkpoint signaling pathways, associates with Hus1 and Rad1 in a heterotrimeric complex (the 9-1-1 complex). Rad9 is inducibly and constitutively phosphorylated. However, the role of Rad9 phosphorylation is unknown. Here we identified nine phosphorylation sites, all of which lie in the carboxyl-terminal 119-amino acid Rad9 "tail," and examined the role of phosphorylation in genotoxin-triggered checkpoint activation. Rad9 mutants lacking a Ser272 phosphorylation site, which is phosphorylated in response to genotoxins, had no effect on survival or checkpoint activation in Mrad9-/- mouse ES cells treated with hydroxyurea (HU), ionizing radiation (IR), or ultraviolet radiation (UV). In contrast, additional Rad9 tail phosphorylation sites were essential for Chk1 activation following HU, IR, and UV treatment. Consistent with a role for Chk1 in S-phase arrest, HU- and UV-induced S-phase arrest was abrogated in the Rad9 phosphorylation mutants. In contrast, however, Rad9 did not play a role in IR-induced S-phase arrest. Clonogenic assays revealed that cells expressing a Rad9 mutant lacking phosphorylation sites were as sensitive as Rad9-/- cells to UV and HU. Although Rad9 contributed to survival of IR-treated cells, the identified phosphorylation sites only minimally contributed to survival following IR treatment. Collectively, these results demonstrate that the Rad9 phospho-tail is a key participant in the Chk1 activation pathway and point to additional roles for Rad9 in cellular responses to IR.
J. Biol. Chem, 10.1074/jbc.M301544200
Submitted on February 13, 2003
Revised on March 27, 2003
Accepted on April 21, 2003
Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. A. Mordes, G. G. Glick, R. Zhao, and D. Cortez TopBP1 activates ATR through ATRIP and a PIKK regulatory domain Genes & Dev., June 1, 2008; 22(11): 1478 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lee, A. Kumagai, and W. G. Dunphy The Rad9-Hus1-Rad1 Checkpoint Clamp Regulates Interaction of TopBP1 with ATR J. Biol. Chem., September 21, 2007; 282(38): 28036 - 28044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Delacroix, J. M. Wagner, M. Kobayashi, K.-i. Yamamoto, and L. M. Karnitz The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1 Genes & Dev., June 15, 2007; 21(12): 1472 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Levitt, M. Zhu, A. Cassano, S. A. Yazinski, H. Liu, J. Darfler, R. M. Peters, and R. S. Weiss Genome Maintenance Defects in Cultured Cells and Mice following Partial Inactivation of the Essential Cell Cycle Checkpoint Gene Hus1 Mol. Cell. Biol., March 15, 2007; 27(6): 2189 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhu and R. S. Weiss Increased Common Fragile Site Expression, Cell Proliferation Defects, and Apoptosis following Conditional Inactivation of Mouse Hus1 in Primary Cultured Cells Mol. Biol. Cell, March 1, 2007; 18(3): 1044 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mahmoudi, J. Mercer, and M. Bennett DNA damage and repair in atherosclerosis Cardiovasc Res, July 15, 2006; 71(2): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lupardus and K. A. Cimprich Phosphorylation of Xenopus Rad1 and Hus1 Defines a Readout for ATR Activation That Is Independent of Claspin and the Rad9 Carboxy Terminus Mol. Biol. Cell, April 1, 2006; 17(4): 1559 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Karnitz, K. S. Flatten, J. M. Wagner, D. Loegering, J. S. Hackbarth, S. J. H. Arlander, B. T. Vroman, M. B. Thomas, Y.-U. Baek, K. M. Hopkins, et al. Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival Mol. Pharmacol., December 1, 2005; 68(6): 1636 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Mesa, D. Loegering, H. L. Powell, K. Flatten, S. J. H. Arlander, N. T. Dai, M. P. Heldebrant, B. T. Vroman, B. D. Smith, J. E. Karp, et al. Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine Blood, July 1, 2005; 106(1): 318 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dang, S. Bao, and X.-F. Wang Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability Genes Cells, April 1, 2005; 10(4): 287 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Karnitz and S. J. H. Arlander Chk1, a Novel Target to Sensitize Tumor Cells to Replication Inhibitors Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 254 - 257. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jurvansuu, K. Raj, A. Stasiak, and P. Beard Viral Transport of DNA Damage That Mimics a Stalled Replication Fork J. Virol., January 1, 2005; 79(1): 569 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Lindsey-Boltz, E. M. Wauson, L. M. Graves, and A. Sancar The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD Nucleic Acids Res., August 23, 2004; 32(15): 4524 - 4530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hopkins, W. Auerbach, X. Y. Wang, M. P. Hande, H. Hang, D. J. Wolgemuth, A. L. Joyner, and H. B. Lieberman Deletion of Mouse Rad9 Causes Abnormal Cellular Responses to DNA Damage, Genomic Instability, and Embryonic Lethality Mol. Cell. Biol., August 15, 2004; 24(16): 7235 - 7248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin, A. Zhu, Y. J. Jin, Y.-X. Liu, X. Zhang, K. M. Hopkins, and H. B. Lieberman Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21 PNAS, June 15, 2004; 101(24): 8864 - 8869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Garg, S. Callens, D.-S. Lim, C. E. Canman, M. B. Kastan, and B. Xu Chromatin Association of Rad17 Is Required for an Ataxia Telangiectasia and Rad-Related Kinase-Mediated S-Phase Checkpoint in Response to Low-Dose Ultraviolet Radiation Mol. Cancer Res., June 1, 2004; 2(6): 362 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Furuya, M. Poitelea, L. Guo, T. Caspari, and A. M. Carr Chk1 activation requires Rad9 S/TQ-site phosphorylation to promote association with C-terminal BRCT domains of Rad4TOPBP1 Genes & Dev., May 15, 2004; 18(10): 1154 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Loegering, S. J. H. Arlander, J. Hackbarth, B. T. Vroman, P. Roos-Mattjus, K. M. Hopkins, H. B. Lieberman, L. M. Karnitz, and S. H. Kaufmann Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death J. Biol. Chem., April 30, 2004; 279(18): 18641 - 18647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, A. Hirano, T. Kumano, S.-L. Xiang, K. Mihara, Y. Haseda, O. Matsui, H. Shimizu, and K.-i. Yamamoto Critical role for chicken Rad17 and Rad9 in the cellular response to DNA damage and stalled DNA replication Genes Cells, April 1, 2004; 9(4): 291 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, C.-L. Hsu, J. Ni, P.-H. Wang, S. Yeh, P. Keng, and C. Chang Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells Mol. Cell. Biol., March 1, 2004; 24(5): 2202 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. H. Arlander, A. K. Eapen, B. T. Vroman, R. J. McDonald, D. O. Toft, and L. M. Karnitz Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress J. Biol. Chem., December 26, 2003; 278(52): 52572 - 52577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Post, A. E. Tomkinson, and E. Y.-H. P. Lee The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase {epsilon} Nucleic Acids Res., October 1, 2003; 31(19): 5568 - 5575. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
